FDA Warns About Byetta for Type 2 Diabetes
Type 2 diabetes can cause damage to the pancreas. So can the drug Byetta that is marketed to help control the symptoms of type 2 diabetes.
In 2008, the FDA warned that Byetta can cause life-threatening pancreas problems. The pancreas produces the body's supply of insulin and releases insulin into the blood stream. It is essential in managing the body's insulin supply.
When a drug causes life-threatening problems, we want to know why.
Our California law firm, Girardi | Keese, has a long history of representing people who have been injured. Our trial lawyers have stood up in court in front of some of the world's biggest corporations - including big drug companies.
When we hear about a drug like Byetta (made by Amylin Pharmaceuticals) that has caused inflammation and bleeding in the pancreas (hemorrhagic pancreatitis), we want to know more. Our attorneys consulted with medical experts to determine what happened and whether the manufacturer should have warned doctors about the dangers.
Hemorrhagic pancreatitis can cause death. Byetta has also been implicated in cases of acute pancreatitis, a sudden inflammation of the pancreas. Because pancreatitis is more common among diabetes patients, it is particularly important to guard against drugs that cause pancreas problems.
Byetta is also marketed as an appetite suppressant.
Type 2 diabetes patients who take Byetta reported weight loss, so the drug began to be used as a weight loss drug by non-diabetics. (The manufacturer does not advocate the drug's use by non-diabetics.) Byetta side effects also include nausea, vomiting, diarrhea and dizziness.
If you know someone who has been injured by Byetta, contact us.